Tower Research Capital »

Cue Biopharma shares owned by Tower Research Capital

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $27k 869 31.56

More positions owned by Tower Research Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Spdr Series Trust St Inter Bd Etf (SPIB)
Micron Technology (MU)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Intel Corporation (INTC)
Ishares Tr 0-3 Mth Treasury (SGOV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Tower Research Capital

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma